Via Surgical is a Haifa, Israel–based developer of novel surgical fixation solutions centered on its trademarked FasTouch™ deployable suture fixation system. Led by co-founder and CEO Lena Levin, the FasTouch systems are designed to make hernia repair surgeries less labor-intensive for surgeons and to reduce patient recovery pain. The company has secured two U.S. Food and Drug Administration 510(k) clearances for the FasTouch™ Absorbable and FasTouch™ Permanent Fixation Systems. New funding will be used to accelerate growth in the APAC region and to support development and production of its suture fixation system. Via Surgical was founded in 2012 and holds 16 issued patents in the U.S. and worldwide, plus 17 additional provisional U.S. patent filings. The company recently received an investment from Catcher Technology to advance its regional expansion and product manufacturing plans. Via Surgical provides the FasTouch™ system, a fixation solution for mesh placement in hernia repair. The company is led by Ofek Levin (CEO), Arik Levy (CTO) and Lena Levin (CFO). It is based in Amirin, Israel. In 2016 the company raised funding to support its development and commercialization efforts. Management stated the funds will be used to increase development and commercialization activity that year. The article does not disclose revenue, users, or other operating metrics.

Total raised

$6M

Funding rounds

2

Latest round

Equity

Latest activity

Feb 2016